| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 11.949 | 26.058 | 9.008 | 17.957 | 20.891 |
| Total Income - EUR | - | - | - | - | - | 11.949 | 26.059 | 9.132 | 17.957 | 20.891 |
| Total Expenses - EUR | - | - | - | - | - | 27 | 893 | 6.207 | 8.033 | 3.245 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 11.922 | 25.166 | 2.924 | 9.923 | 17.646 |
| Net Profit/Loss - EUR | - | - | - | - | - | 11.572 | 24.384 | 2.651 | 8.574 | 14.964 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Docmednephro S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 1.118 | 9.212 | 6.885 | 5.092 |
| Current Assets | - | - | - | - | - | 11.914 | 34.905 | 18.808 | 4.380 | 10.549 |
| Inventories | - | - | - | - | - | 0 | 0 | 4.499 | 0 | 0 |
| Receivables | - | - | - | - | - | 3.655 | 4.484 | 0 | 1.484 | 0 |
| Cash | - | - | - | - | - | 8.259 | 30.421 | 14.309 | 2.896 | 10.549 |
| Shareholders Funds | - | - | - | - | - | 11.455 | 24.433 | 2.699 | 11.265 | 15.012 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 459 | 11.590 | 25.321 | 0 | 628 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Docmednephro S.r.l.